ArticleACS omega2025
Novel Antimicrobial-Decorated Polyelectrolytes as Versatile Building Blocks for Multifunctional Hydrogel Nano- and Microparticles.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The construction of multipurpose particles with functional coatings of varying structure and composition provides the opportunity to modify their physicochemical and biological characteristics. In accordance with the aforementioned, new polyelectrolytes (PEs) decorated with an antimicrobial function (PEs-DAF) were designed and prepared to apply them as building blocks of a various carrier systems. A series of hydrogel nano- and microparticles were developed and coated with an outer PE shell with antimicrobial functionality. To this end, poly-(acrylic acid) (PAA) was grafted with different degrees of substitution (DS) of antimicrobial essential oils such as thymol (THY), menthol (MEN), and carvacrol (CAR) (abbreviated as PAA-X-DS% (X = THY, MEN, CAR; DS = 5,15)) using Steglich esterification under mild reaction conditions. Their structures were confirmed by
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.